China holds roundtable with over 50 foreign pharmaceutical firms
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/18/2026
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Oil touches $110 a barrel for first time since May on Middle East, Russia supply fears
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Apple’s first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
Tweet
Share
E-mail
Get Alerts SNY Hot Sheet
Join SI Premium – FREE
Investing.com -- China's commerce ministry met with representatives from more than 50 foreign pharmaceutical companies on Friday, according to a ministry statement.
The meeting included companies such as Sanofi, Novartis, BD, Danaher, Merck, Eli Lilly, and Gilead Sciences, the statement showed.
Ling Ji, a vice commerce minister who led the meeting, said China is committed to improving pricing mechanisms and regulatory systems for the health care sector. Ji added that China welcomes pharmaceutical companies from all countries to deepen their presence in the Chinese market.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Softbank Said To Weigh Buying Largest Us Security Firm Allied - Bloomberg
- L&T Financial Holdings (LTFH:IN) PT Lowered to INR330 at UBS
- DLF Ltd. (DLFU:IN) PT Raised to INR830 at Jefferies
Create E-mail Alert Related Categories
InvestingRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
